EGFR and glioblastoma: Recently, it has also been demonstrated that PACAP causes EGFR transactivation in non-small cell lung cancer in an oxygen-dependent manner that involves phospholipase C but not protein kinase A. Therefore, it could be hypothesized that the peptide’ effect in GBM may be mediated through a similar mechanism [146,147,148].